NOVO Nordisk has informed the TGA that the supply of Ozempic (semaglutide) in Australia remains limited.
They expect the supply to remain limited until the end of Jun (PD 16 Feb).
Patients who are prescribed Ozempic should contact their doctor to have their treatment reassessed, the TGA said.
The above article was sent to subscribers in Pharmacy Daily's issue from 14 Apr 23
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 14 Apr 23
Warning: Undefined variable $o_shortcode_atts in /home/pharmacydaily.com.au/public_html/wp-content/themes/child-custom-theme/functions.php on line 1263
Warning: Undefined variable $output in /home/pharmacydaily.com.au/public_html/wp-content/themes/child-custom-theme/functions.php on line 1266
